APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Nivolumab Injection

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Nivolumab Injection Market Analysis and Forecast 2026-2032

Report ID 17401733022 January 2026190 pages

Choose your research edition.

Industry ResearchNivolumab Injection Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Nivolumab Injection Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Nivolumab Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nivolumab Injection Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Nivolumab Injection Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Nivolumab Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Nivolumab Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Nivolumab Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Nivolumab Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Nivolumab Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Nivolumab Injection include Sinopharm, AbbVie, Ono Pharmaceutical, Bristol-Myers Squibb and Allergan, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Nivolumab Injection, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Nivolumab Injection, also provides the sales of main regions and countries. Of the upcoming market potential for Nivolumab Injection, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Nivolumab Injection sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Nivolumab Injection market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Nivolumab Injection sales, projected growth trends, production technology, application and end-user industry.

Nivolumab Injection Segment by Company

Sinopharm

AbbVie

Ono Pharmaceutical

Bristol-Myers Squibb

Allergan

Nivolumab Injection Segment by Type

100IU

50IU

Other

Nivolumab Injection Segment by Application

Metastatic Squamous NSCLC

Metastatic Melanoma

Renal Cell Carcinoma

Classical Hodgkin Lymphoma

Unresectable Melanoma

Other

Nivolumab Injection Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nivolumab Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nivolumab Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nivolumab Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Nivolumab Injection in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Nivolumab Injection manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Nivolumab Injection sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Nivolumab Injection Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 100IU Major Manufacturers Table 3. 50IU Major Manufacturers Table 4. Other Major Manufacturers Table 5. Global Nivolumab Injection Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Metastatic Squamous NSCLC Major Manufacturers Table 7. Metastatic Melanoma Major Manufacturers Table 8. Renal Cell Carcinoma Major Manufacturers Table 9. Classical Hodgkin Lymphoma Major Manufacturers Table 10. Unresectable Melanoma Major Manufacturers Table 11. Other Major Manufacturers Table 12. Nivolumab Injection Industry Trends Table 13. Nivolumab Injection Industry Drivers Table 14. Nivolumab Injection Industry Opportunities and Challenges Table 15. Nivolumab Injection Industry Restraints Table 16. Global Nivolumab Injection Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Nivolumab Injection Revenue by Region (2021-2026) & (US$ Million) Table 18. Global Nivolumab Injection Revenue by Region (2027-2032) & (US$ Million) Table 19. Global Nivolumab Injection Revenue Market Share by Region (2021-2026) Table 20. Global Nivolumab Injection Revenue Market Share by Region (2027-2032) Table 21. Global Nivolumab Injection Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (Units) Table 22. Global Nivolumab Injection Sales by Region (2021-2026) & (Units) Table 23. Global Nivolumab Injection Sales by Region (2027-2032) & (Units) Table 24. Global Nivolumab Injection Sales Market Share by Region (2021-2026) Table 25. Global Nivolumab Injection Sales Market Share by Region (2027-2032) Table 26. Global Nivolumab Injection Revenue by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Nivolumab Injection Revenue Market Share by Manufacturers (2021-2026) Table 28. Global Nivolumab Injection Sales by Manufacturers (US$ Million) & (2021-2026) Table 29. Global Nivolumab Injection Sales Market Share by Manufacturers (2021-2026) Table 30. Global Nivolumab Injection Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 31. Global Nivolumab Injection Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 32. Global Nivolumab Injection Key Manufacturers Manufacturing Sites & Headquarters Table 33. Global Nivolumab Injection Manufacturers, Product Type & Application Table 34. Global Nivolumab Injection Manufacturers' Establishment Date Table 35. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 36. Global Nivolumab Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 37. Global Nivolumab Injection Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Nivolumab Injection Revenue by Type (2021-2026) & (US$ Million) Table 39. Global Nivolumab Injection Revenue by Type (2027-2032) & (US$ Million) Table 40. Global Nivolumab Injection Revenue Market Share by Type (2021-2026) Table 41. Global Nivolumab Injection Revenue Market Share by Type (2027-2032) Table 42. Global Nivolumab Injection Sales by Type 2021 VS 2025 VS 2032 (Units) Table 43. Global Nivolumab Injection Sales by Type (2021-2026) & (Units) Table 44. Global Nivolumab Injection Sales by Type (2027-2032) & (Units) Table 45. Global Nivolumab Injection Sales Market Share by Type (2021-2026) Table 46. Global Nivolumab Injection Sales Market Share by Type (2027-2032) Table 47. Global Nivolumab Injection Price by Type (2021-2026) & (US$/Unit) Table 48. Global Nivolumab Injection Price by Type (2027-2032) & (US$/Unit) Table 49. Global Nivolumab Injection Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Nivolumab Injection Revenue by Application (2021-2026) & (US$ Million) Table 51. Global Nivolumab Injection Revenue by Application (2027-2032) & (US$ Million) Table 52. Global Nivolumab Injection Revenue Market Share by Application (2021-2026) Table 53. Global Nivolumab Injection Revenue Market Share by Application (2027-2032) Table 54. Global Nivolumab Injection Sales by Application 2021 VS 2025 VS 2032 (Units) Table 55. Global Nivolumab Injection Sales by Application (2021-2026) & (Units) Table 56. Global Nivolumab Injection Sales by Application (2027-2032) & (Units) Table 57. Global Nivolumab Injection Sales Market Share by Application (2021-2026) Table 58. Global Nivolumab Injection Sales Market Share by Application (2027-2032) Table 59. Global Nivolumab Injection Price by Application (2021-2026) & (US$/Unit) Table 60. Global Nivolumab Injection Price by Application (2027-2032) & (US$/Unit) Table 61. Sinopharm Company Information Table 62. Sinopharm Business Overview Table 63. Sinopharm Nivolumab Injection Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 64. Sinopharm Nivolumab Injection Product Portfolio Table 65. Sinopharm Recent Development Table 66. AbbVie Company Information Table 67. AbbVie Business Overview Table 68. AbbVie Nivolumab Injection Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. AbbVie Nivolumab Injection Product Portfolio Table 70. AbbVie Recent Development Table 71. Ono Pharmaceutical Company Information Table 72. Ono Pharmaceutical Business Overview Table 73. Ono Pharmaceutical Nivolumab Injection Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Ono Pharmaceutical Nivolumab Injection Product Portfolio Table 75. Ono Pharmaceutical Recent Development Table 76. Bristol-Myers Squibb Company Information Table 77. Bristol-Myers Squibb Business Overview Table 78. Bristol-Myers Squibb Nivolumab Injection Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Bristol-Myers Squibb Nivolumab Injection Product Portfolio Table 80. Bristol-Myers Squibb Recent Development Table 81. Allergan Company Information Table 82. Allergan Business Overview Table 83. Allergan Nivolumab Injection Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Allergan Nivolumab Injection Product Portfolio Table 85. Allergan Recent Development Table 86. North America Nivolumab Injection Revenue by Type (2021-2026) & (US$ Million) Table 87. North America Nivolumab Injection Revenue by Type (2027-2032) & (US$ Million) Table 88. North America Nivolumab Injection Sales by Type (2021-2026) & (Units) Table 89. North America Nivolumab Injection Sales by Type (2027-2032) & (Units) Table 90. North America Nivolumab Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 91. North America Nivolumab Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 92. North America Nivolumab Injection Revenue by Application (2021-2026) & (US$ Million) Table 93. North America Nivolumab Injection Revenue by Application (2027-2032) & (US$ Million) Table 94. North America Nivolumab Injection Sales by Application (2021-2026) & (Units) Table 95. North America Nivolumab Injection Sales by Application (2027-2032) & (Units) Table 96. North America Nivolumab Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 97. North America Nivolumab Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 98. North America Nivolumab Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 99. North America Nivolumab Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 100. North America Nivolumab Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 101. North America Nivolumab Injection Sales by Country (2021 VS 2025 VS 2032) & (Units) Table 102. North America Nivolumab Injection Sales by Country (2021-2026) & (Units) Table 103. North America Nivolumab Injection Sales by Country (2027-2032) & (Units) Table 104. North America Nivolumab Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 105. North America Nivolumab Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 106. United States Nivolumab Injection Revenue (2021-2032) & (US$ Million) Table 107. Canada Nivolumab Injection Revenue (2021-2032) & (US$ Million) Table 108. Europe Nivolumab Injection Revenue by Type (2021-2026) & (US$ Million) Table 109. Europe Nivolumab Injection Revenue by Type (2027-2032) & (US$ Million) Table 110. Europe Nivolumab Injection Sales by Type (2021-2026) & (Units) Table 111. Europe Nivolumab Injection Sales by Type (2027-2032) & (Units) Table 112. Europe Nivolumab Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 113. Europe Nivolumab Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 114. Europe Nivolumab Injection Revenue by Application (2021-2026) & (US$ Million) Table 115. Europe Nivolumab Injection Revenue by Application (2027-2032) & (US$ Million) Table 116. Europe Nivolumab Injection Sales by Application (2021-2026) & (Units) Table 117. Europe Nivolumab Injection Sales by Application (2027-2032) & (Units) Table 118. Europe Nivolumab Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 119. Europe Nivolumab Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 120. Europe Nivolumab Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 121. Europe Nivolumab Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 122. Europe Nivolumab Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 123. Europe Nivolumab Injection Sales by Country (2021 VS 2025 VS 2032) & (Units) Table 124. Europe Nivolumab Injection Sales by Country (2021-2026) & (Units) Table 125. Europe Nivolumab Injection Sales by Country (2027-2032) & (Units) Table 126. Europe Nivolumab Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 127. Europe Nivolumab Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 128. Germany Nivolumab Injection Revenue (2021-2032) & (US$ Million) Table 129. France Nivolumab Injection Revenue (2021-2032) & (US$ Million) Table 130. U.K. Nivolumab Injection Revenue (2021-2032) & (US$ Million) Table 131. Italy Nivolumab Injection Revenue (2021-2032) & (US$ Million) Table 132. Netherlands Nivolumab Injection Revenue (2021-2032) & (US$ Million) Table 133. China Nivolumab Injection Revenue by Type (2021-2026) & (US$ Million) Table 134. China Nivolumab Injection Revenue by Type (2027-2032) & (US$ Million) Table 135. China Nivolumab Injection Sales by Type (2021-2026) & (Units) Table 136. China Nivolumab Injection Sales by Type (2027-2032) & (Units) Table 137. China Nivolumab Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 138. China Nivolumab Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 139. China Nivolumab Injection Revenue by Application (2021-2026) & (US$ Million) Table 140. China Nivolumab Injection Revenue by Application (2027-2032) & (US$ Million) Table 141. China Nivolumab Injection Sales by Application (2021-2026) & (Units) Table 142. China Nivolumab Injection Sales by Application (2027-2032) & (Units) Table 143. China Nivolumab Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 144. China Nivolumab Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 145. Asia Nivolumab Injection Revenue by Type (2021-2026) & (US$ Million) Table 146. Asia Nivolumab Injection Revenue by Type (2027-2032) & (US$ Million) Table 147. Asia Nivolumab Injection Sales by Type (2021-2026) & (Units) Table 148. Asia Nivolumab Injection Sales by Type (2027-2032) & (Units) Table 149. Asia Nivolumab Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 150. Asia Nivolumab Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 151. Asia Nivolumab Injection Revenue by Application (2021-2026) & (US$ Million) Table 152. Asia Nivolumab Injection Revenue by Application (2027-2032) & (US$ Million) Table 153. Asia Nivolumab Injection Sales by Application (2021-2026) & (Units) Table 154. Asia Nivolumab Injection Sales by Application (2027-2032) & (Units) Table 155. Asia Nivolumab Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 156. Asia Nivolumab Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 157. Asia Nivolumab Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 158. Asia Nivolumab Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 159. Asia Nivolumab Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 160. Asia Nivolumab Injection Sales by Country (2021 VS 2025 VS 2032) & (Units) Table 161. Asia Nivolumab Injection Sales by Country (2021-2026) & (Units) Table 162. Asia Nivolumab Injection Sales by Country (2027-2032) & (Units) Table 163. Asia Nivolumab Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 164. Asia Nivolumab Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 165. Japan Nivolumab Injection Revenue (2021-2032) & (US$ Million) Table 166. South Korea Nivolumab Injection Revenue (2021-2032) & (US$ Million) Table 167. India Nivolumab Injection Revenue (2021-2032) & (US$ Million) Table 168. Australia Nivolumab Injection Revenue (2021-2032) & (US$ Million) Table 169. China Taiwan Nivolumab Injection Revenue (2021-2032) & (US$ Million) Table 170. Southeast Asia Nivolumab Injection Revenue (2021-2032) & (US$ Million) Table 171. SAMEA Nivolumab Injection Revenue by Type (2021-2026) & (US$ Million) Table 172. SAMEA Nivolumab Injection Revenue by Type (2027-2032) & (US$ Million) Table 173. SAMEA Nivolumab Injection Sales by Type (2021-2026) & (Units) Table 174. SAMEA Nivolumab Injection Sales by Type (2027-2032) & (Units) Table 175. SAMEA Nivolumab Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 176. SAMEA Nivolumab Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 177. SAMEA Nivolumab Injection Revenue by Application (2021-2026) & (US$ Million) Table 178. SAMEA Nivolumab Injection Revenue by Application (2027-2032) & (US$ Million) Table 179. SAMEA Nivolumab Injection Sales by Application (2021-2026) & (Units) Table 180. SAMEA Nivolumab Injection Sales by Application (2027-2032) & (Units) Table 181. SAMEA Nivolumab Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 182. SAMEA Nivolumab Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 183. SAMEA Nivolumab Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 184. SAMEA Nivolumab Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 185. SAMEA Nivolumab Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 186. SAMEA Nivolumab Injection Sales by Country (2021 VS 2025 VS 2032) & (Units) Table 187. SAMEA Nivolumab Injection Sales by Country (2021-2026) & (Units) Table 188. SAMEA Nivolumab Injection Sales by Country (2027-2032) & (Units) Table 189. SAMEA Nivolumab Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 190. SAMEA Nivolumab Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 191. Brazil Nivolumab Injection Revenue (2021-2032) & (US$ Million) Table 192. Argentina Nivolumab Injection Revenue (2021-2032) & (US$ Million) Table 193. Chile Nivolumab Injection Revenue (2021-2032) & (US$ Million) Table 194. Colombia Nivolumab Injection Revenue (2021-2032) & (US$ Million) Table 195. Peru Nivolumab Injection Revenue (2021-2032) & (US$ Million) Table 196. Saudi Arabia Nivolumab Injection Revenue (2021-2032) & (US$ Million) Table 197. Israel Nivolumab Injection Revenue (2021-2032) & (US$ Million) Table 198. UAE Nivolumab Injection Revenue (2021-2032) & (US$ Million) Table 199. Turkey Nivolumab Injection Revenue (2021-2032) & (US$ Million) Table 200. Iran Nivolumab Injection Revenue (2021-2032) & (US$ Million) Table 201. Egypt Nivolumab Injection Revenue (2021-2032) & (US$ Million) Table 202. Key Raw Materials Table 203. Raw Materials Key Suppliers Table 204. Nivolumab Injection Distributors List Table 205. Nivolumab Injection Customers List Table 206. Research Programs/Design for This Report Table 207. Authors List of This Report Table 208. Secondary Sources Table 209. Primary Sources List of Figures Figure 1. Nivolumab Injection Image Figure 2. Global Nivolumab Injection Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Nivolumab Injection Market Size Share 2021 VS 2025 VS 2032 Figure 4. 100IU Image Figure 5. 50IU Image Figure 6. Other Image Figure 7. Global Nivolumab Injection Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Nivolumab Injection Market Size Share 2021 VS 2025 VS 2032 Figure 9. Metastatic Squamous NSCLC Image Figure 10. Metastatic Melanoma Image Figure 11. Renal Cell Carcinoma Image Figure 12. Classical Hodgkin Lymphoma Image Figure 13. Unresectable Melanoma Image Figure 14. Other Image Figure 15. Global Nivolumab Injection Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Nivolumab Injection Revenue (2021-2032) & (US$ Million) Figure 17. Global Nivolumab Injection Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global Nivolumab Injection Revenue Market Share by Region: 2025 Versus 2032 Figure 19. Global Nivolumab Injection Revenue Market Share by Region (2021-2032) Figure 20. Global Nivolumab Injection Sales (2021-2032) & (Units) Figure 21. Global Nivolumab Injection Sales by Region: 2021 VS 2025 VS 2032 (Units) Figure 22. Global Nivolumab Injection Sales Market Share by Region (2021-2032) Figure 23. US & Canada & Mexico Nivolumab Injection Sales YoY (2021-2032) & (Units) Figure 24. Europe Nivolumab Injection Sales YoY (2021-2032) & (Units) Figure 25. China Nivolumab Injection Sales YoY (2021-2032) & (Units) Figure 26. Asia (Excluding China) Nivolumab Injection Sales YoY (2021-2032) & (Units) Figure 27. South America, Middle East and Africa Nivolumab Injection Sales YoY (2021-2032) & (Units) Figure 28. Global Nivolumab Injection Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 29. Global Nivolumab Injection Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 30. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Global Nivolumab Injection Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 32. Global Nivolumab Injection Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Nivolumab Injection Revenue Market Share by Type (2021-2032) Figure 34. Global Nivolumab Injection Sales by Type (2021 VS 2025 VS 2032) & (Units) Figure 35. Global Nivolumab Injection Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 36. Global Nivolumab Injection Sales Market Share by Type (2021-2032) Figure 37. Global Nivolumab Injection Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 38. Global Nivolumab Injection Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Nivolumab Injection Revenue Market Share by Application (2021-2032) Figure 40. Global Nivolumab Injection Sales by Application (2021 VS 2025 VS 2032) & (Units) Figure 41. Global Nivolumab Injection Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 42. Global Nivolumab Injection Sales Market Share by Application (2021-2032) Figure 43. North America Nivolumab Injection Revenue Share by Type (2021-2032) Figure 44. North America Nivolumab Injection Sales Share by Type (2021-2032) Figure 45. North America Nivolumab Injection Revenue Share by Application (2021-2032) Figure 46. North America Nivolumab Injection Sales Share by Application (2021-2032) Figure 47. North America Nivolumab Injection Revenue Share by Country (2021-2032) Figure 48. North America Nivolumab Injection Sales Share by Country (2021-2032) Figure 49. Europe Nivolumab Injection Revenue Share by Type (2021-2032) Figure 50. Europe Nivolumab Injection Sales Share by Type (2021-2032) Figure 51. Europe Nivolumab Injection Revenue Share by Application (2021-2032) Figure 52. Europe Nivolumab Injection Sales Share by Application (2021-2032) Figure 53. Europe Nivolumab Injection Revenue Share by Country (2021-2032) Figure 54. Europe Nivolumab Injection Sales Share by Country (2021-2032) Figure 55. China Nivolumab Injection Revenue Share by Type (2021-2032) Figure 56. China Nivolumab Injection Sales Share by Type (2021-2032) Figure 57. China Nivolumab Injection Revenue Share by Application (2021-2032) Figure 58. China Nivolumab Injection Sales Share by Application (2021-2032) Figure 59. Asia Nivolumab Injection Revenue Share by Type (2021-2032) Figure 60. Asia Nivolumab Injection Sales Share by Type (2021-2032) Figure 61. Asia Nivolumab Injection Revenue Share by Application (2021-2032) Figure 62. Asia Nivolumab Injection Sales Share by Application (2021-2032) Figure 63. Asia Nivolumab Injection Revenue Share by Country (2021-2032) Figure 64. Asia Nivolumab Injection Sales Share by Country (2021-2032) Figure 65. SAMEA Nivolumab Injection Revenue Share by Type (2021-2032) Figure 66. SAMEA Nivolumab Injection Sales Share by Type (2021-2032) Figure 67. SAMEA Nivolumab Injection Revenue Share by Application (2021-2032) Figure 68. SAMEA Nivolumab Injection Sales Share by Application (2021-2032) Figure 69. SAMEA Nivolumab Injection Revenue Share by Country (2021-2032) Figure 70. SAMEA Nivolumab Injection Sales Share by Country (2021-2032) Figure 71. Nivolumab Injection Value Chain Figure 72. Manufacturing Cost Structure Figure 73. Nivolumab Injection Production Mode & Process Figure 74. Direct Comparison with Distribution Share Figure 75. Distributors Profiles Figure 76. Years Considered Figure 77. Research Process Figure 78. Key Executives Interviewed

Scope & coverage.

Types
  • 100IU
  • 50IU
  • Other
Applications
  • Metastatic Squamous NSCLC
  • Metastatic Melanoma
  • Renal Cell Carcinoma
  • Classical Hodgkin Lymphoma
  • Unresectable Melanoma
  • Other
Companies covered
  • Sinopharm
  • AbbVie
  • Ono Pharmaceutical
  • Bristol-Myers Squibb
  • Allergan

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Nivolumab Injection Market by Type
  3. 1.2.1 Global Nivolumab Injection Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 100IU
  5. 1.2.3 50IU
  6. 1.2.4 Other
  7. 1.3 Nivolumab Injection Market by Application
  8. 1.3.1 Global Nivolumab Injection Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Metastatic Squamous NSCLC
  10. 1.3.3 Metastatic Melanoma
  11. 1.3.4 Renal Cell Carcinoma
  12. 1.3.5 Classical Hodgkin Lymphoma
  13. 1.3.6 Unresectable Melanoma
  14. 1.3.7 Other
  15. 1.4 Assumptions and Limitations
  16. 1.5 Study Goals and Objectives
2 Nivolumab Injection Market Dynamics
  1. 2.1 Nivolumab Injection Industry Trends
  2. 2.2 Nivolumab Injection Industry Drivers
  3. 2.3 Nivolumab Injection Industry Opportunities and Challenges
  4. 2.4 Nivolumab Injection Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Nivolumab Injection Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Nivolumab Injection Revenue by Region
  3. 3.2.1 Global Nivolumab Injection Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Nivolumab Injection Revenue by Region (2021-2026)
  5. 3.2.3 Global Nivolumab Injection Revenue by Region (2027-2032)
  6. 3.2.4 Global Nivolumab Injection Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Nivolumab Injection Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Nivolumab Injection Sales by Region
  9. 3.4.1 Global Nivolumab Injection Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Nivolumab Injection Sales by Region (2021-2026)
  11. 3.4.3 Global Nivolumab Injection Sales by Region (2027-2032)
  12. 3.4.4 Global Nivolumab Injection Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Nivolumab Injection Revenue by Manufacturers
  2. 4.1.1 Global Nivolumab Injection Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Nivolumab Injection Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Nivolumab Injection Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Nivolumab Injection Sales by Manufacturers
  6. 4.2.1 Global Nivolumab Injection Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Nivolumab Injection Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Nivolumab Injection Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Nivolumab Injection Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Nivolumab Injection Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Nivolumab Injection Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Nivolumab Injection Manufacturers, Product Type & Application
  13. 4.7 Global Nivolumab Injection Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Nivolumab Injection Market CR5 and HHI
  16. 4.8.2 2025 Nivolumab Injection Tier 1, Tier 2, and Tier 3
5 Nivolumab Injection Market by Type
  1. 5.1 Global Nivolumab Injection Revenue by Type
  2. 5.1.1 Global Nivolumab Injection Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Nivolumab Injection Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Nivolumab Injection Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Nivolumab Injection Sales by Type
  6. 5.2.1 Global Nivolumab Injection Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Nivolumab Injection Sales by Type (2021-2032) & (Units)
  8. 5.2.3 Global Nivolumab Injection Sales Market Share by Type (2021-2032)
  9. 5.3 Global Nivolumab Injection Price by Type
6 Nivolumab Injection Market by Application
  1. 6.1 Global Nivolumab Injection Revenue by Application
  2. 6.1.1 Global Nivolumab Injection Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Nivolumab Injection Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Nivolumab Injection Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Nivolumab Injection Sales by Application
  6. 6.2.1 Global Nivolumab Injection Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Nivolumab Injection Sales by Application (2021-2032) & (Units)
  8. 6.2.3 Global Nivolumab Injection Sales Market Share by Application (2021-2032)
  9. 6.3 Global Nivolumab Injection Price by Application
7 Company Profiles
  1. 7.1 Sinopharm
  2. 7.1.1 Sinopharm Company Information
  3. 7.1.2 Sinopharm Business Overview
  4. 7.1.3 Sinopharm Nivolumab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Sinopharm Nivolumab Injection Product Portfolio
  6. 7.1.5 Sinopharm Recent Developments
  7. 7.2 AbbVie
  8. 7.2.1 AbbVie Company Information
  9. 7.2.2 AbbVie Business Overview
  10. 7.2.3 AbbVie Nivolumab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 AbbVie Nivolumab Injection Product Portfolio
  12. 7.2.5 AbbVie Recent Developments
  13. 7.3 Ono Pharmaceutical
  14. 7.3.1 Ono Pharmaceutical Company Information
  15. 7.3.2 Ono Pharmaceutical Business Overview
  16. 7.3.3 Ono Pharmaceutical Nivolumab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Ono Pharmaceutical Nivolumab Injection Product Portfolio
  18. 7.3.5 Ono Pharmaceutical Recent Developments
  19. 7.4 Bristol-Myers Squibb
  20. 7.4.1 Bristol-Myers Squibb Company Information
  21. 7.4.2 Bristol-Myers Squibb Business Overview
  22. 7.4.3 Bristol-Myers Squibb Nivolumab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Bristol-Myers Squibb Nivolumab Injection Product Portfolio
  24. 7.4.5 Bristol-Myers Squibb Recent Developments
  25. 7.5 Allergan
  26. 7.5.1 Allergan Company Information
  27. 7.5.2 Allergan Business Overview
  28. 7.5.3 Allergan Nivolumab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Allergan Nivolumab Injection Product Portfolio
  30. 7.5.5 Allergan Recent Developments
8 North America
  1. 8.1 North America Nivolumab Injection Market Size by Type
  2. 8.1.1 North America Nivolumab Injection Revenue by Type (2021-2032)
  3. 8.1.2 North America Nivolumab Injection Sales by Type (2021-2032)
  4. 8.1.3 North America Nivolumab Injection Price by Type (2021-2032)
  5. 8.2 North America Nivolumab Injection Market Size by Application
  6. 8.2.1 North America Nivolumab Injection Revenue by Application (2021-2032)
  7. 8.2.2 North America Nivolumab Injection Sales by Application (2021-2032)
  8. 8.2.3 North America Nivolumab Injection Price by Application (2021-2032)
  9. 8.3 North America Nivolumab Injection Market Size by Country
  10. 8.3.1 North America Nivolumab Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Nivolumab Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Nivolumab Injection Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Nivolumab Injection Market Size by Type
  2. 9.1.1 Europe Nivolumab Injection Revenue by Type (2021-2032)
  3. 9.1.2 Europe Nivolumab Injection Sales by Type (2021-2032)
  4. 9.1.3 Europe Nivolumab Injection Price by Type (2021-2032)
  5. 9.2 Europe Nivolumab Injection Market Size by Application
  6. 9.2.1 Europe Nivolumab Injection Revenue by Application (2021-2032)
  7. 9.2.2 Europe Nivolumab Injection Sales by Application (2021-2032)
  8. 9.2.3 Europe Nivolumab Injection Price by Application (2021-2032)
  9. 9.3 Europe Nivolumab Injection Market Size by Country
  10. 9.3.1 Europe Nivolumab Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Nivolumab Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Nivolumab Injection Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Nivolumab Injection Market Size by Type
  2. 10.1.1 China Nivolumab Injection Revenue by Type (2021-2032)
  3. 10.1.2 China Nivolumab Injection Sales by Type (2021-2032)
  4. 10.1.3 China Nivolumab Injection Price by Type (2021-2032)
  5. 10.2 China Nivolumab Injection Market Size by Application
  6. 10.2.1 China Nivolumab Injection Revenue by Application (2021-2032)
  7. 10.2.2 China Nivolumab Injection Sales by Application (2021-2032)
  8. 10.2.3 China Nivolumab Injection Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Nivolumab Injection Market Size by Type
  2. 11.1.1 Asia Nivolumab Injection Revenue by Type (2021-2032)
  3. 11.1.2 Asia Nivolumab Injection Sales by Type (2021-2032)
  4. 11.1.3 Asia Nivolumab Injection Price by Type (2021-2032)
  5. 11.2 Asia Nivolumab Injection Market Size by Application
  6. 11.2.1 Asia Nivolumab Injection Revenue by Application (2021-2032)
  7. 11.2.2 Asia Nivolumab Injection Sales by Application (2021-2032)
  8. 11.2.3 Asia Nivolumab Injection Price by Application (2021-2032)
  9. 11.3 Asia Nivolumab Injection Market Size by Country
  10. 11.3.1 Asia Nivolumab Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Nivolumab Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Nivolumab Injection Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Nivolumab Injection Market Size by Type
  2. 12.1.1 SAMEA Nivolumab Injection Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Nivolumab Injection Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Nivolumab Injection Price by Type (2021-2032)
  5. 12.2 SAMEA Nivolumab Injection Market Size by Application
  6. 12.2.1 SAMEA Nivolumab Injection Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Nivolumab Injection Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Nivolumab Injection Price by Application (2021-2032)
  9. 12.3 SAMEA Nivolumab Injection Market Size by Country
  10. 12.3.1 SAMEA Nivolumab Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Nivolumab Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Nivolumab Injection Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Nivolumab Injection Value Chain Analysis
  2. 13.1.1 Nivolumab Injection Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Nivolumab Injection Production Mode & Process
  6. 13.2 Nivolumab Injection Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Nivolumab Injection Distributors
  9. 13.2.3 Nivolumab Injection Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst